Bigatab®90 (Brigatinib) 90mg

Introduction to Alunbrig (Brigatinib) 90mg 

Alunbrig (Brigatinib) 90mg is a targeted prescription medicine used in the treatment of certain types of lung cancer, specifically non-small cell lung cancer (NSCLC) that is ALK-positive. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking cancer growth signals.

Bigatab®90 (Brigatinib) 90mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Oral Anticancer Drugs. It contains Brigatinib, which targets abnormal proteins responsible for cancer cell growth and survival.

In some regions, Bigatab®90 90mg is available as a generic version of Brigatinib, providing similar therapeutic effects when prescribed by a qualified healthcare professional.

What Is Alunbrig (Brigatinib) 90mg? 

Alunbrig is the original brand name for Brigatinib, an oral targeted therapy used primarily for ALK-positive non-small cell lung cancer.

Brigatinib belongs to the tyrosine kinase inhibitor (TKI) class of medicines. These drugs block specific enzymes (kinases) involved in cancer cell growth.

Generic versions such as Bigatab®90 90mg contain the same active ingredient and may be used based on physician recommendation and availability.

Drug Class and Mechanism of Action 

Brigatinib is classified as a tyrosine kinase inhibitor with antineoplastic properties.

How Brigatinib Works 

It works in several ways:

• Inhibits ALK (anaplastic lymphoma kinase) activity
• Blocks cancer cell signaling pathways
• Prevents tumor growth and spread

Through these mechanisms, Brigatinib helps control cancer progression.

How Alunbrig Works in the Body 

Brigatinib targets specific proteins that drive cancer cell growth, especially in ALK-positive lung cancer.

Key Actions of Brigatinib 

• Blocks abnormal ALK protein activity
• Slows tumor growth
• Promotes cancer cell death

Generic versions like Bigatab®90 provide similar therapeutic effects when used appropriately.

Medical Uses of Alunbrig (Brigatinib) 90mg 

Bigatab®90 90mg is primarily used in oncology treatment.

Brigatinib for Non-Small Cell Lung Cancer (NSCLC) 

It is used in patients with ALK-positive metastatic NSCLC.

Potential Benefits 

• Targets specific cancer mutations
• Slows disease progression
• Improves survival outcomes

Who Can Take Bigatab®90 (Brigatinib) 90mg? 

This medicine must be used under specialist supervision.

Eligibility Criteria 

Patients may be prescribed Brigatinib if they:

• Have ALK-positive non-small cell lung cancer
• Require targeted therapy
• Have been evaluated by an oncologist

Who Should Avoid Alunbrig (Brigatinib) 90mg 

Brigatinib should NOT be used by:

• Patients with hypersensitivity to Brigatinib
• Individuals with severe uncontrolled medical conditions without monitoring
• Pregnant women unless prescribed under strict medical supervision

Alunbrig (Brigatinib) 90mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

• Initial dose: 90mg once daily for 7 days
• Then increased to 180mg once daily if tolerated
• Taken with or without food

Dosage Adjustments 

Doctors may adjust the dose depending on:

• Patient tolerance
• Side effects
• Liver function

Side Effects of Brigatinib 90mg 

Like all cancer medicines, Brigatinib may cause side effects.

Common Side Effects 

• Nausea
• Diarrhea
• Fatigue
• Headache

Serious Side Effects 

• Lung inflammation (early onset pulmonary events)
• High blood pressure
• Liver enzyme elevation
• Vision problems

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 30°C in a dry place, away from moisture and light. Keep out of reach of children.

Frequently Asked Questions (FAQs) 

1. What is Bigatab®90 (Brigatinib) 90mg used for? 

It is used to treat ALK-positive non-small cell lung cancer.

2. Is Brigatinib a chemotherapy drug? 

No. It is a targeted therapy (tyrosine kinase inhibitor), not traditional chemotherapy.

3. How long does it take to work? 

Patients may start seeing benefits within weeks, but response varies.

4. Can Brigatinib be taken with food? 

Yes. It can be taken with or without food.

5. Is Bigatab®90 the same as Alunbrig? 

Yes. It contains Brigatinib, the same active ingredient as Alunbrig.

6. Do I need a prescription for Bigatab®90 90mg? 

Yes. It is a prescription-only medicine.

7. Can pregnant women take Brigatinib? 

No. It may harm the unborn baby and should be avoided unless prescribed.

Medical Disclaimer 

Disclaimer:
The information provided is for educational purposes only and should not be considered medical advice. Brigatinib is a prescription-only medicine and must be used under the supervision of a qualified healthcare professional. Always consult your doctor before starting or stopping any medication.